Literature DB >> 1724598

Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer.

P Narayan1, R Dahiya.   

Abstract

The present experiments were conducted to examine and characterize the lipid composition of benign prostatic hyperplasia (BPH) and prostatic cancer tissues (CAP). Lipids were extracted from these tissues and analyzed by thin layer chromatography (TLC) and gas liquid chromatography (GLC). The protein profiles of these tissues were analyzed by SDS-polyacrylamide gel electrophoresis. The results of these studies demonstrate that the principal lipids of BPH and CAP tissues are phosphatidyl choline, phosphatidyl ethanolamine, sphingomyelin, fatty acids and cholesterol. The sphingomyelin level is significantly higher in CAP tissues compared to BPH tissues. The differences in the enzymatic activities responsible for the biosynthesis and degradation of sphingomyelin appear to explain at least partially the alteration in sphingomyelin level between BPH and CAP tissues. The major fatty acids of phosphatidyl choline and phosphatidyl ethanolamine were palmitic (16:0), stearic (18:0), oleic (18:1) and arachidonic (20:4) acid. The arachidonic acid level was significantly decreased in CAP tissues compared to BPH tissues. SDS polyacrylamide gel electrophoresis revealed several protein differences between BPH and CAP tissues. The most significant difference was the decrease in 12 kDa protein in CAP tissues compared to BPH. The present data, therefore, suggests that there are significant alterations in sphingomyelin, fatty acids and protein profiles between BPH and CAP tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724598

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  6 in total

Review 1.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

2.  Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

Authors:  Jiazhong Jiang; Blake Lee Neubauer; Jeremy R Graff; Marcio Chedid; James E Thomas; Neal W Roehm; Shaobo Zhang; George J Eckert; Michael O Koch; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.

Authors:  Joanna D Stewart; Rosemarie Marchan; Michaela S Lesjak; Joerg Lambert; Roland Hergenroeder; James K Ellis; Chung-Ho Lau; Hector C Keun; Gerd Schmitz; Juergen Schiller; Mandy Eibisch; Christian Hedberg; Herbert Waldmann; Ekkehart Lausch; Berno Tanner; Jalid Sehouli; Jens Sagemueller; Hagen Staude; Eric Steiner; Jan G Hengstler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-08       Impact factor: 11.205

4.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.

Authors:  Carissa F Santos; John Kurhanewicz; Z Laura Tabatabai; Jeffry P Simko; Kayvan R Keshari; Akpene Gbegnon; Romelyn Delos Santos; Scot Federman; Katsuto Shinohara; Peter R Carroll; Christopher M Haqq; Mark G Swanson
Journal:  NMR Biomed       Date:  2009-12-23       Impact factor: 4.044

5.  A UHPLC-Mass Spectrometry View of Human Melanocytic Cells Uncovers Potential Lipid Biomarkers of Melanoma.

Authors:  Arantza Perez-Valle; Beatriz Abad-García; Olatz Fresnedo; Gabriel Barreda-Gómez; Patricia Aspichueta; Aintzane Asumendi; Egoitz Astigarraga; José A Fernández; María Dolores Boyano; Begoña Ochoa
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

6.  Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Julie A Schmidt; Georgina K Fensom; Sabina Rinaldi; Augustin Scalbert; Paul N Appleby; David Achaintre; Audrey Gicquiau; Marc J Gunter; Pietro Ferrari; Rudolf Kaaks; Tilman Kühn; Anna Floegel; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Eleutherios Anifantis; Claudia Agnoli; Domenico Palli; Morena Trevisan; Rosario Tumino; H Bas Bueno-de-Mesquita; Antonio Agudo; Nerea Larrañaga; Daniel Redondo-Sánchez; Aurelio Barricarte; José Maria Huerta; J Ramón Quirós; Nick Wareham; Kay-Tee Khaw; Aurora Perez-Cornago; Mattias Johansson; Amanda J Cross; Konstantinos K Tsilidis; Elio Riboli; Timothy J Key; Ruth C Travis
Journal:  BMC Med       Date:  2017-07-05       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.